Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta Study
Motoo Nagane(Kyorin University), Kazuhiko Mishima, Nobuyoshi Sasaki(Kyorin University), Jun Muto(Fujita Health University), Tomoo Matsutani(Chiba University), Shigeru Yamaguchi(Hokkaido University), Jun‐ichiro Kuroda(Kumamoto University), Manabu Natsumeda(Niigata University), Naoto Tomita(St. Marianna University School of Medicine), Yasukazu Kawai(Fukui Prefectural Hospital), Fumiyuki Yamasaki(Hiroshima University), Manabu Kinoshita(Asahikawa Medical University), Keiichiro Hattori(University of Tsukuba), Kensuke Tateishi(Yokohama City University), Hajime Yonezawa(Kagoshima University), Takeshi Okuda, Keita Kinoshita(Hirosaki University), Noriaki Kitamura(University of Occupational and Environmental Health Japan), Fumiharu Ohka(Nagoya University), Yoshitaka Narita(Unknown), Hiroyuki Sugahara(Sumitomo Hospital)
Cited by 1
Related Papers
Apparent Diffusion Coefficient of Human Brain Tumors at MR Imaging
|Radiology|2005|505
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice
|Journal of Hepatology|2010|284